ESElena Samohvalov

Elena Samohvalov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elena Samohvalov has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • What is hidden after Acute Coronary Syndrome?

    by Silvia Filimon, Liviu Grib, Alexandra Grejdieru, Elena Samohvalov, Andreea Filimon, Nicolae Lutica

    Stress ("Tako-Tsubo") cardiomyopathy or Takotsubo syndrome (TTS), is characterized by acute but rapidly reversible LV systolic dysfunction in the absence of atherosclerotic coronary artery disease, triggered by strong psychological, physical or iatrogenic stress. Takotsubo syndrome is a complex and still poorly recognized heart disease with a wide spectrum of possible clinical presentations. Despite its reversibility, it is associated with serious adverse in-hospital events and high complication rates during follow-up. Multimodal imaging is helpful for establishing the diagnosis, guiding therapy, and stratifying prognosis of TTS patients in both the acute and post-acute phase. This article describes the clinical case of a 67-year-old woman who, after a strong emotional stress, presented with clinical manifestations of ACS. Following laboratory tests and investigations (ECG, Echocardiography, Chest X-ray, Coronary angiography, Ventriculography) the diagnosis of Takotsubo Syndrome was established. Based on treatment with beta-adrenoblockers, anticoagulants, dual antiplatelet therapy (Aspirin+Clopidogrel), nitrates, statins, metabolic drugs (Mildronate), the patient"s condition improved, with the recovery of left ventricular systolic function.

  • Risk factors and key points in cardiogenic shock

    by Lucia Girbu, Liviu Grib, Alexandra Grajdieru, Elena Samohvalov, Iraida Camerzan

    Cardiogenic shock is an acute, complex, and multifactorial syndrome caused by severe cardiac dysfunction leading to low cardiac output and tissue hypoperfusion. Identified risk factors (RFs) include: age >75 years, female sex, anterior or extensive acute myocardial infarction (AMI), angina pectoris, peripheral vascular disease, ejection fraction (EF) less 30%, mitral regurgitation, and diabetes mellitus. Early diagnosis, advanced hemodynamic monitoring (HM) using PiCCO, identification of mortality-associated RFs, and guidance of fluid and vasopressor therapy are key points in CS management with a major impact on reducing mortality. The aim of our study was to assess mortality-associated RFs in CS and demonstrate the benefit of advanced HM via PiCCO in optimizing treatment and improving outcomes. Out of 86 analyzed parameters, we identified: 6 common RFs for both groups (PiCCO and ECHO): NT-proBNP >4N, acute pulmonary edema, cerebral edema, troponin >2N, total bilirubin >4N, creatinine >2N; 7 PiCCO-specific RFs: VO₂ less 100 ml/min, DO₂ less 250 ml/min, coma, right ventricular AMI, ERO₂ >60%, PaCO₂ >50 mmHg, hemoglobin less 9.0 g/dL; 9 ECHO-specific RFs: hepatomegaly, oliguria less 30 ml/h, pyelonephritis, transmural AMI, hepatic failure, stroke, inferior and anteroinferior AMI, lactate >2 mmol/L. All patients with ≥5 RFs (PiCCO group) and ≥7 RFs (ECHO group) died (100%). Male patients had a higher mortality rate (35.8% vs. 26.4%). PiCCO monitoring enabled individualized guidance of fluid and vasopressor therapy, early detection of cardiogenic pulmonary edema, and differentiation from non-cardiogenic forms. Mortality was significantly lower in the PiCCO group compared to the ECHO group (36.5% vs. 62.3%, p=0.0112).

  • Open Access

    A rare case of tuberculous polyserositis

    by Inga Harghel, Elena Samohvalov, Diana Lupu

    Polyserositis in tuberculosis is a sign of a form of extrapulmonary tuberculosis, which can be associated with a severe course of the disease and often requires intensive treatment with antituberculosis antibiotics and sometimes surgery to control complications. The diagnosis of polyserositis due to tuberculosis is complex and challenging, which can cause delays in treatment. This article represents the case of patient P., with generalized tuberculosis, polyserositis, bacteriologically confirmed (by culture, BACTEC), evolutionary phase. To confirm the diagnosis, specific tuberculosis examinations were performed: BAAR, GeneXpert, BACTEC. Biochemical examination of the blood, oncogenic markers, thyroid gland hormones, microscopic and biochemical examination of the pleural fluid, chest x-rays, repeated echocardiography, abdominal and thoracic CT, abdominal ultrasonography were performed, which allowed the exclusion of other causes of polyserositis and the application of medication election. Against the background of specific antibiotic treatment, the patient’s condition improved and the exudates regressed.